Giulia Mentrasti

835 total citations
15 papers, 190 citations indexed

About

Giulia Mentrasti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Giulia Mentrasti has authored 15 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Giulia Mentrasti's work include Economic and Financial Impacts of Cancer (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Giulia Mentrasti is often cited by papers focused on Economic and Financial Impacts of Cancer (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Giulia Mentrasti collaborates with scholars based in Italy, Sweden and Netherlands. Giulia Mentrasti's co-authors include Rossana Berardi, Riccardo Giampieri, Silvia Rinaldi, Mariangela Torniai, Francesca Morgese, Federica Pecci, Luca Cantini, Rita Chiari, Linda Nicolardi and Joachim G.J.V. Aerts and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

Giulia Mentrasti

14 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Mentrasti Italy 6 104 58 44 25 17 15 190
Edmund M. Qiao United States 8 84 0.8× 56 1.0× 47 1.1× 18 0.7× 9 0.5× 35 183
Prasanth Penumadu India 9 68 0.7× 67 1.2× 82 1.9× 28 1.1× 9 0.5× 53 214
Jong Soo Lee South Korea 9 77 0.7× 44 0.8× 61 1.4× 78 3.1× 19 1.1× 29 293
Zoey Chopra United States 8 37 0.4× 58 1.0× 33 0.8× 25 1.0× 7 0.4× 27 203
Ho Seok Chung South Korea 10 55 0.5× 133 2.3× 91 2.1× 17 0.7× 53 3.1× 48 320
Gregory A. Williams United States 9 176 1.7× 78 1.3× 157 3.6× 11 0.4× 47 2.8× 29 288
Carolyn Aldigé United States 5 62 0.6× 62 1.1× 29 0.7× 42 1.7× 6 0.4× 8 241
Facundo Zaffaroni Brazil 6 70 0.7× 68 1.2× 50 1.1× 26 1.0× 10 0.6× 16 177
Nan Lu China 9 71 0.7× 39 0.7× 70 1.6× 18 0.7× 33 1.9× 30 290
Zhentao Fu China 9 74 0.7× 39 0.7× 43 1.0× 15 0.6× 40 2.4× 32 180

Countries citing papers authored by Giulia Mentrasti

Since Specialization
Citations

This map shows the geographic impact of Giulia Mentrasti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Mentrasti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Mentrasti more than expected).

Fields of papers citing papers by Giulia Mentrasti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Mentrasti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Mentrasti. The network helps show where Giulia Mentrasti may publish in the future.

Co-authorship network of co-authors of Giulia Mentrasti

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Mentrasti. A scholar is included among the top collaborators of Giulia Mentrasti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Mentrasti. Giulia Mentrasti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Aprile, Giuseppe, et al.. (2024). Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches. Critical Reviews in Oncology/Hematology. 206. 104571–104571.
2.
Fancelli, Sara, Enrico Caliman, Francesca Mazzoni, et al.. (2022). KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population. Frontiers in Oncology. 12. 968064–968064. 5 indexed citations
3.
Mentrasti, Giulia, Luca Cantini, Patrizia Vici, et al.. (2022). Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study. The Breast. 65. 164–171. 15 indexed citations
4.
Bittoni, Alessandro, Riccardo Giampieri, Federica Pecci, et al.. (2021). Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients. Current Oncology. 28(5). 3525–3536. 1 indexed citations
5.
Cantini, Luca, Giulia Mentrasti, Nicla La Verde, et al.. (2021). 35P Lung cancer diagnosis and continuum of care: How did the COVID-19 outbreak impact? Data from an Italian multicenter study. Journal of Thoracic Oncology. 16(4). S713–S713. 1 indexed citations
6.
Bittoni, Alessandro, Federica Pecci, Giulia Mentrasti, et al.. (2021). Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer. Annals of Translational Medicine. 9(3). 251–251. 31 indexed citations
7.
Berardi, Rossana, Giulia Mentrasti, Nicla La Verde, et al.. (2021). 1609P COVID-19 outbreak repercussions on breast cancer diagnoses and access to treatment: Preliminary data from the COVID-DELAY study. Annals of Oncology. 32. S1149–S1149. 1 indexed citations
8.
Cantini, Luca, Federica Pecci, Veronica Agostinelli, et al.. (2021). The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. Journal of Clinical Medicine. 10(5). 1005–1005. 34 indexed citations
9.
Berardi, Rossana, Francesca Morgese, Silvia Rinaldi, et al.. (2020). Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Mentrasti, Giulia, Mariangela Torniai, Riccardo Giampieri, et al.. (2020). Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Berardi, Rossana, Francesca Morgese, Silvia Rinaldi, et al.. (2020). <p>Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management</p>. Cancer Management and Research. Volume 12. 9363–9374. 74 indexed citations
12.
Mentrasti, Giulia, Mariangela Torniai, Riccardo Giampieri, et al.. (2020). <p>Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management</p>. Therapeutics and Clinical Risk Management. Volume 16. 663–672. 23 indexed citations
13.
Giampieri, Riccardo, Elena Maccaroni, Federica Pecci, et al.. (2019). Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia. SHILAP Revista de lepidopterología. 8(1). 161–169. 1 indexed citations
14.
Daniel, Francesca, et al.. (2017). The regorafenib issue: focus on efficacy and safety in pre-treated metastatic colorectal cancer from a real world experience. Annals of Oncology. 28. vi15–vi16. 1 indexed citations
15.
Sclafani, Francesco, Ian Chau, David Cunningham, et al.. (2016). KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial. Annals of Oncology. 27. vi173–vi173. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026